Additional Supporting Information may be found in the online version of this article.

MDS_22562_sm_SuppInfo.doc34KSupporting Information
MDS_22562_sm_SuppFig-1.doc31KSupporting Figure 1: Short-, intermediate-, and long-term effects of iron sucrose and placebo on RLS symptoms. Shown as the median values of the IRLS score at baseline (week 0) and at follow up weeks 3, 7, 11, and months 5, 8, and 12. (ITT analysis, n=29 for the iron sucrose group and n=31 for the placebo group)
MDS_22562_sm_SuppTable-1.doc58KSupporting Table 1: Adverse reactions during the study. Number of adverse reactions and percentage of all reported reactions listed in certain categories. Different events may have occurred in one individual patient and at repeated occasions.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.